Trials / Completed
CompletedNCT04639492
Postbiotic MBS and Metformin Combination in Patients With T2DM
Evaluating the Effect and Safety of Postbiotic MBS and Metformin Combination on Gut Microbiota and Symptom in Patients With Diabetes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Microbio Co Ltd · Industry
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective is to evaluate the effect of MBS treatment in human subjects, and to validate its impact on intestinal flora and diabetes symptoms on diabetic patients undertaking metformin. The scientific data collected will be referenced for future product development.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | MBS oral solution | Oral BIDAC, twice a day before breakfast and dinner times |
Timeline
- Start date
- 2020-11-02
- Primary completion
- 2022-06-30
- Completion
- 2022-09-23
- First posted
- 2020-11-20
- Last updated
- 2023-01-05
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT04639492. Inclusion in this directory is not an endorsement.